Rosen J M,Raught B,Hadsell D.The mammary gland as a bioreactor:factors regulating the efficient expression of milk protein based transgenes[J].Am J Clin Nutr(Supplement),1996,63:627-632.
[2]
Sedivy J M,Vogelstein B,Liber H L,et al.Gene targeting in human cells without isogenic DNA[J].Science,1999,283:abstract.
[3]
Sedivy J M,Sharp P A.Positive genetic selection for gene disruption in mammalian cells by homologous recombination[J].Pro Natl Acad Sci,USA,1989,86:227-231.
[4]
Jeannotte L,Ruiz J C,Robertson E J.Low level of Hox1.3 gene expression does not preclude the use of promoterless vectors to generate a targeted gene disruption[J].Off Mol Cell Biol,1991,11:5578-5585.
[5]
Shjichiri M,Hanson K D,Sedivy J M.Effects of c-myc expression on proliferation,qiuescence,and the G0 to G1 transition in nontransformed cells[J].Cell Growth Differ,1993,4:93-104.
McGreath K J,Howcroft J,campbell K H S,et al.Production of gene-targeted sheep by nuclear transfer from cultured somatic cells[J].Nature,2000,405:1066-1069.
[9]
Denning C,Burl S,Ainslie A,et al.Deletion of the alpha(1,3) galactosyl transferase(GGTA1) gene and the prion protein(PrP) gene in sheep[J].Nat Biotechnol,2001,19:559-562.
[10]
Te Riile H,Robanus M,Berns A.Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs[J].Pro Natl Acad Sci,USA,89:5128-5132.
[11]
Deng C,Capecchi M R.Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus[J].Mol Cell Biol,1992,12:3365-3371.
[12]
Yanez R J,Porter A C G.Therapeutic gene targeting[J].Gene Ther,1998,5:149-159.
[13]
Shulman M J,Nissen L,Collins C.Homologous recombination in hybridoma cells:dependence on time and fragment length[J].Mol Cell Biol,1990,10:4466-4472.
[14]
Thomas K R,Deng C,Capecchi M R.High-fedelity gene targeting in embryonic stem cells by using sequence replacement vectors[J].Mol Cell Biol,1992,12:2919-2923.
[15]
Shjichiri M,Hanson K D,Sedivy J M.Effects of c-myc expression on proliferation,qiuescence,and the G0 to G1 transition in nontransformed cells[J].Cell Growth Differ,1993,4:93-104.
[16]
Mansour S L,Thomas K R,Capecchi M R.Disruption of the protooncogene int-2 in mouse embryo-derived stem cells:a general strategy for targeting mutations to non-selectable genes[J].Natrue,1988,336:348-352.
[17]
Thomas K R,Capecchi M R.Targeted disruption of the murine int-1 pro-oncogene resulting in severe abnormalities in midbrain and cerebellar development[J].Nature,1990,346:847-850.
[18]
Hanson K D,Sedivy J M.Analysis of biological selections for high-efficiency gene targeting[J].Mol Cell Biol,1995,15:45-51.
[19]
Revet B M,Sena E P,Zarling D A.Homologous DNA targeting with RecA protein coated short DNA probes and electronmicroscope mapping on linear duplex molecules[J].J Mol Biol,1993,232:779-791.
[20]
Mekeel K L,Tang W,Kachnic L A,et al.Inactivation of p53 results in high rates of homologous recombination[J].Oncogene,1997,14:1847-1857.
[21]
Xiang Y,Cole-Strauss A,Yoon K,et al.Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide[J].J Mol Med,1997,75:829-835.
